Travere Therapeutics (TVTX) Current Leases: 2020-2025
Historic Current Leases for Travere Therapeutics (TVTX) over the last 4 years, with Sep 2025 value amounting to $5.7 million.
- Travere Therapeutics' Current Leases rose 8.25% to $5.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.7 million, marking a year-over-year increase of 8.25%. This contributed to the annual value of $5.4 million for FY2024, which is 10.10% up from last year.
- Per Travere Therapeutics' latest filing, its Current Leases stood at $5.7 million for Q3 2025, which was up 2.48% from $5.6 million recorded in Q2 2025.
- In the past 5 years, Travere Therapeutics' Current Leases ranged from a high of $5.7 million in Q3 2025 and a low of $3.9 million during Q4 2021.
- Over the past 3 years, Travere Therapeutics' median Current Leases value was $5.2 million (recorded in 2024), while the average stood at $5.1 million.
- Data for Travere Therapeutics' Current Leases shows a peak YoY spiked of 994.68% (in 2021) over the last 5 years.
- Quarterly analysis of 5 years shows Travere Therapeutics' Current Leases stood at $3.9 million in 2021, then climbed by 13.43% to $4.4 million in 2022, then climbed by 10.74% to $4.9 million in 2023, then increased by 10.10% to $5.4 million in 2024, then climbed by 8.25% to $5.7 million in 2025.
- Its Current Leases was $5.7 million in Q3 2025, compared to $5.6 million in Q2 2025 and $5.5 million in Q1 2025.